Influenza vaccination in patients with acute heart failure (PANDA II): study protocol for a hospital-based, parallel-group, cluster randomized controlled trial in China
This trial was registered with the acronym PANDA II (Population Assessment of Influenza and Disease Activity) at ChiCTR.org.cn (ChiCTR2100053264). Registered on 17 November 2021.
Authors
- Craig S. Anderson (ORCID: https://orcid.org/0000-0002-7248-4863)
- Xin Du (ORCID: https://orcid.org/0000-0002-7463-8707)
- Zhiyan Wang (ORCID: https://orcid.org/0000-0001-7910-3245)
- Jianzeng Dong (ORCID: https://orcid.org/0000-0001-7299-7805)
- Dong Han (ORCID: https://orcid.org/0000-0002-6083-6913)
- Yiqun Zhang (ORCID: https://orcid.org/0009-0000-5811-4439)
- Chi Wang (ORCID: https://orcid.org/0000-0002-2550-2168)
- Rong Liu (ORCID: https://orcid.org/0000-0002-8609-5463)
- Qiang Li (ORCID: https://orcid.org/0000-0002-4897-1012)
- Yangyang Zhao (ORCID: https://orcid.org/0000-0002-5697-3288)
Institutions
- Sinopec (China) (CN)
- Capital Medical University (CN)
- Fudan University (CN)
- UNSW Sydney (AU)
- The George Institute for Global Health (AU)
- Beijing Anzhen Hospital (CN)
- China National Health Development Research Center (CN)
- First Affiliated Hospital of Zhengzhou University (CN)
- George Institute for Global Health (CN)
- Shanghai Center for Brain Science and Brain-Inspired Technology (CN)
Publication Details
- Journal
- Trials
- Published
- 2024-11-25
- DOI
- https://doi.org/10.1186/s13063-024-08452-8
- Citations
- 3
- Primary Topic
- Influenza Virus Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 1.16
Funders
- Sanofi